Insurtech Investment Falls to 1.36 Billion Dollars in Third Quarter
.jpg)
Global Insurance Desk: Global insurtech funding dropped 44.6 percent quarter over quarter to 1.36 billion dollars in the third quarter of 2026, down from 1.76 billion dollars in the prior three months, as a sharp pullback in oversized deals weighed on total sector investment.
According to the Global InsurTech Report for Q3 2026 published by Gallagher Re and reported by Insurance Asia, total transaction counts edged down slightly from 107 to 104, while mega round funding plunged from 1.67 billion dollars in the second quarter to 660 million dollars in the third.
Life and health startups continued to outpace their property and casualty peers for the third straight quarter, even though funding in the segment tumbled 66.7 percent to 610 million dollars from 1.84 billion dollars previously. Four of the five largest transactions during the period went to life and health firms, led by Angle Health raising 200 million dollars, Forus securing 150 million dollars, and Thatch and Penelope Health bringing in 100 million dollars apiece. Combined, those four deals accounted for three quarters of the 741.54 million dollars raised across 31 life and health transactions.
While late stage capital tightened, early stage momentum picked up considerably. Early stage investment climbed 20.1 percent from the previous quarter to 117.29 million dollars across 56 transactions, up from 95.9 million dollars across 46 deals in the second quarter. Seed and angel stage startups represented 42.3 percent of all insurtech transactions during the period, marking their highest share of deal volume since the fourth quarter of 2022.
Geographically, activity remained heavily concentrated in the United States, where domestic firms captured 64.4 percent of global deals, an increase of 3.7 percentage points from the prior quarter and 11.8 percentage points year over year. American startups accounted for 67 of the 104 global transactions, far ahead of the United Kingdom and India with seven deals each. Gallagher Re noted that this concentration mirrors the investor base, as 75.9 percent of active insurtech backers in the third quarter were based in the United States.
Artificial intelligence remained the dominant theme across the market, drawing 83.2 percent of all capital deployed during the quarter. AI focused firms secured 1.13 billion dollars across 72 transactions, highlighted by Penelope Health and Oxbridge Health, which raised 100 million dollars and 38.5 million dollars respectively. Conversely, digital credit startups have attracted just one percent of cumulative sector funding since 2012, totaling 681.8 million dollars across 78 companies.
Corporate backing from traditional carriers also cooled, with reinsurance and insurer backed funding rounds falling from 51 in the third quarter of 2025 to 25 in the third quarter of 2026. Among active incumbent investors, entities tied to MS&AD Group led the market for a second consecutive quarter, with Mitsui Sumitomo Insurance Venture Capital backing three deals and MS&AD Ventures participating in two.